Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer
舒鲁法替尼联合托瑞普利单抗(一种无化疗方案)治疗晚期胃/胃食管交界处腺癌、食管鳞状细胞癌或胆道癌患者的疗效和安全性
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03677-7
Zhang, Panpan; Chen, Zhendong; Shi, Si; Li, Zhiping; Ye, Feng; Song, Lijie; Zhang, Yanqiao; Yin, Fei; Zhang, Xing; Xu, Jianming; Cheng, Ying; Su, Weiguo; Shi, Michael; Fan, Songhua; Tan, Panfeng; Zhong, Chen; Lu, Ming; Shen, Lin